Company news

TCGX Acquisition Corp. news

Latest news releases, newest first.

TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migraine

October 19, 2026

TCGX Acquisition Corp. II Announces Pricing of $100,000,000 Initial Public Offering

October 15, 2026

TCGX Acquisition Corp. Announces Completion of its Initial Public Offering

August 6, 2026

Decks

SPAC Merger (October 2026)
SPAC merger · 31 slides · Oct 19, 2026